Massimo Cristofanilli, Professor of Medicine & Associate Director of Precision Medicine at Weill Cornell Medicine, shared on LinkedIn:
“Today, I’m celebrating 40 years since graduating with my medical degree from Sapienza – Università di Roma.
I still remember arriving alone at the train station on a sunny day, carrying my thesis with pride and excitement. My family couldn’t be there – and my father, whom we had lost to bladder cancer a few years earlier, was deeply missed. His life and loss inspired my path in oncology and shaped the compassionate care I strive to provide.
My thesis in experimental pathology was my first step into translational research. I became fascinated by genetics and biomarkers, and I knew that continuing laboratory research would help me become a better physician.
That day marked the achievement of a goal – and a family dream – but it was also the beginning of a much longer journey to discover my role and purpose.
I’m grateful to the many people who nurtured my curiosity and taught me that knowledge is always evolving. My mentor, Prof. Alberto Pellegrini, gave me a strong foundation in breast cancer care.
Later, the next chapter took me abroad – a decision that brought opportunity, but also the sacrifice of leaving family, friends, and precious moments behind.
I was fortunate to have the unwavering support of my wife, Dr. Barbara Pro, who joined me and built her own career.
Dr. Richard Pazdur, Dr. Gabriel Bast, and Dr. John Mendelsohn gave me the opportunity to pursue fellowship training at UT MD Anderson.
There, I learned alongside extraordinary leaders in breast oncology, including Dr. Gabriel Hortobagyi.
My work on circulating tumor cells, alongside Dr. Daniel Hayes, led to an important early contribution to the field of liquid biopsy. I went on to co-found the ISLB, PMAC, and DCan Biosciences, with the shared goal of advancing precision medicine through earlier detection and screening.
A particular source of pride has been my work in inflammatory breast cancer (IBC):
launching the Morgan Welch IBC Research Program and Clinic at MD Anderson with Dr. Tom Buchholz, and bringing investigators together through the Inflammatory Breast Cancer International Consortium (IBC-IC).
I’m equally proud of the fellows, trainees, and junior faculty I’ve had the privilege of mentoring over the past three decades. Their kind words at conferences are a reminder that our efforts can make a lasting difference – and that we must keep paying it forward.
When I picture that young doctor walking along Viale dell’Università with his thesis in hand, I could not have imagined all that lay ahead.
Today, I look back with gratitude for the people, lessons, and opportunities that shaped the journey – and for the chance to keep learning, serving, and contributing.”
You can also read:
